These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1412647)

  • 21. Use of difluoromethylornithine (DFMO, eflornithine) for late-stage African trypanosomiasis.
    McCann PP; Bitonti AJ; Bacchi CJ; Clarkson AB
    Trans R Soc Trop Med Hyg; 1987; 81(4):701-2. PubMed ID: 3127968
    [No Abstract]   [Full Text] [Related]  

  • 22. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
    Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
    Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Cymelarsan in the treatment of natural chronic Trypanosoma evansi infection in camels in the Sudan.
    Musa MM; Abdoon AM; Nasir BT; Salim YI; Abdel-Rahman AY; Shommein AM
    Rev Elev Med Vet Pays Trop; 1994; 47(4):397-400. PubMed ID: 7770663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suramin treatment of experimental Trypanosoma brucei infection of the central nervous system.
    Jennings FW
    Trans R Soc Trop Med Hyg; 1995; 89(6):677. PubMed ID: 8594694
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of experimental trypanosomiasis in pigs.
    Jibike GI; Anika SM
    Br Vet J; 1991; 147(6):556-64. PubMed ID: 1777799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya.
    Bales JD; Harrison SM; Mbwabi DL; Schecter PJ
    Ann Trop Med Parasitol; 1989 Aug; 83 Suppl 1():111-4. PubMed ID: 2515816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. African sleeping sickness in the United States. Successful treatment with eflornithine.
    Petru AM; Azimi PH; Cummins SK; Sjoerdsma A
    Am J Dis Child; 1988 Feb; 142(2):224-8. PubMed ID: 3124603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potentiation of arsenicals with difluoromethylornithine (DFMO): experimental studies in murine trypanosomiasis.
    Jennings FW
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):595-607. PubMed ID: 2848638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eflornithine for African sleeping sickness.
    Sjoerdsma A; Schechter PJ
    Lancet; 1999 Jul; 354(9174):254. PubMed ID: 10421331
    [No Abstract]   [Full Text] [Related]  

  • 30. NECT trial: more than a small victory over sleeping sickness.
    Opigo J; Woodrow C
    Lancet; 2009 Jul; 374(9683):7-9. PubMed ID: 19559477
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of late stage rhodesiense trypanosomiasis using suramin and eflornithine: report of six cases.
    Clerinx J; Taelman H; Bogaerts J; Vervoort T
    Trans R Soc Trop Med Hyg; 1998; 92(4):449-50. PubMed ID: 9850406
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemotherapy of CNS-trypanosomiasis: the combined use of the arsenicals and nitro-compounds.
    Jennings FW
    Trop Med Parasitol; 1991 Jun; 42(2):139-42. PubMed ID: 1896771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further studies on difluoromethylornithine in African trypanosomes.
    McCann PP; Bacchi CJ; Clarkson AB; Seed JR; Nathan HC; Amole BO; Hutner SH; Sjoerdsma A
    Med Biol; 1981 Dec; 59(5-6):434-40. PubMed ID: 6175860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug resistance in human African trypanosomiasis.
    Barrett MP; Vincent IM; Burchmore RJ; Kazibwe AJ; Matovu E
    Future Microbiol; 2011 Sep; 6(9):1037-47. PubMed ID: 21958143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The rise and fall of sleeping sickness.
    Barrett MP
    Lancet; 2006 Apr; 367(9520):1377-8. PubMed ID: 16650633
    [No Abstract]   [Full Text] [Related]  

  • 36. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.
    Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U
    Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
    Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
    Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Cymelarsan and Diminasan against Trypanosoma equiperdum infections in mice and horses.
    Hagos A; Goddeeris BM; Yilkal K; Alemu T; Fikru R; Yacob HT; Feseha G; Claes F
    Vet Parasitol; 2010 Aug; 171(3-4):200-6. PubMed ID: 20417035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy of trypanosomiasis: the use of guanylhydrazone compounds in the treatment of experimental murine trypanosomiasis.
    Jennings FW; Ulrich P; Cerami A
    Trop Med Parasitol; 1987 Sep; 38(3):181-6. PubMed ID: 3124253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do we need new drugs against human African trypanosomiasis?
    Stich A; Ponte-Sucre A; Holzgrabe U
    Lancet Infect Dis; 2013 Sep; 13(9):733-4. PubMed ID: 23969207
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.